Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion type Assertion NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_head.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion description "[These results contribute to a deeper understanding of the properties of transgenic lymphocytes used to treat human malignancies and may provide a rationale for the development of combination therapies as a method to improve ACT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_provenance.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion evidence source_evidence_literature NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_provenance.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion SIO_000772 23861247 NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_provenance.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion wasDerivedFrom befree-20140225 NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_provenance.
- NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_assertion wasGeneratedBy ECO_0000203 NP566851.RAHaGvFOCPgBV9d60qWN8cazceCB8YOWy9avJWaDJi5uE130_provenance.